Asco 2022 – early focus settles on Adicet | Evaluate

Retrieved on: 2022-04-28 17:25:26

Tags for this article:

Click the tags to see associated articles and topics

Asco 2022 – early focus settles on Adicet | Evaluate. View article details on hiswai:

Excerpt

Prominent biopharma datasets ; Enhertu, Anti-Her2 ADC, Astrazeneca/Daiichi Sankyo ; Trodelvy, Anti-Trop2 MAb, Gilead ; Patritumab deruxtecan ...

Article found on: www.evaluate.com